Evidence map›Paper›PMID 28500618›Full record

ArticleMedical oncology (Northwood, London, England)2017

Prognostic value of ABO blood types in young patients with breast cancer; a nationwide study in Korean Breast Cancer Society.

Sungmin Park, Ku Sang Kim, Jeong-Soo Kim, Wonshik Han, Byeong-Woo Park, Seokwon Lee, Ye Won Jeon, Se Kyung Lee, Jonghan Yu, Jeong Eon Lee and 3 more

Abstract read
PubMed Publisher
In one paragraph

Article in Medical oncology (Northwood, London, England), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Observational
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Sungmin ParkDepartment of Surgery, Chungbuk National University Hospital, College of Medicine, Chungbuk National University, Cheongju, South Korea.
Ku Sang KimBreast-Thyroid Center, Ulsan City Hospital, Ulsan City Hospital Group, Ulsan, South Korea.
Jeong-Soo KimDepartment of Surgery, Uijeongbu St. Mary's Hospital, Catholic University, Uijeongbu, South Korea.
Wonshik HanDepartment of Surgery and Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea.
Byeong-Woo ParkDepartment of Surgery, Yonsei University College of Medicine, Seoul, South Korea.
Seokwon LeeDepartment of Surgery, Pusan National University Hospital, Pusan National University College of Medicine, Busan, South Korea.
Ye Won JeonDepartment of Surgery, St. Vincent's Hospital, College of Medicine, Catholic University, Suwon, South Korea.
Se Kyung LeeDivision of Breast Surgery, Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
Jonghan YuDivision of Breast Surgery, Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
Jeong Eon LeeDivision of Breast Surgery, Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
Seok Won KimDivision of Breast Surgery, Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
Seok Jin NamDivision of Breast Surgery, Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea. seokjin.nam@samsung.com.
Korean Breast Cancer Society

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The purpose of this study was to investigate the relationship between ABO blood types and breast cancer survival in young Korean patients. This was a retrospective study of 115,474 patients who were surgically treated for primary breast cancer between 1987 and 2011 in Korea. All data were collected by the Korean Breast Cancer Society (KBCS) online breast cancer registry. Each hospital serologically examined the ABO blood types of patients before surgery. There was no significant difference in overall survival (OS) or breast cancer-specific survival (BCSS) among ABO blood types. Type of surgery; T stage; N stage; histologic grade; status of estrogen receptor, progesterone receptor, and HER2; and chemotherapy were significant prognostic factors of OS and BCSS in univariate analysis and multivariate analyses. Compared to women with blood type O, there was a difference in OS and BCSS for blood type A, blood type B, or blood type AB. Compared to blood group non-O, patients with blood group O were more likely to have favorable prognosis when younger than 40 years. Further follow-up studies are necessary to clarify the role of the impact of ABO blood types on prognosis of breast cancer.

Indexed as

ABO Blood-Group SystemAdultBreast NeoplasmsFemaleHumansKaplan-Meier EstimatePrognosisRepublic of KoreaRetrospective StudiesYoung AdultABO Blood-Group SystemABO blood typeBreast cancerPrognosisYoung breast cancer

Identifiers

PMID28500618

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.